25 Years of Advancing Hematologic Malignancies: The Lymphoma, Leukemia and Myeloma Congress
Lymphoma, Leukemia and Myeloma Congress shared a post on X:
“This Thanksgiving, we’re especially grateful for you — Our LL&M Congress family.
Thank you for your dedication, passion, and commitment to advancing care for patients with blood cancers.
Here’s to continued learning, innovation, and making a difference together!”
For 24 years, the Lymphoma, Leukemia & Myeloma Congress has served as the premier educational event focused on hematologic malignancies.
Each October, more than 75 leading experts from around the world come together in New York to present the latest clinical data, debate optimal treatment strategies, and share best practices with one of the largest live audiences in the field.
The rigorous scientific program features presentations, panel discussions, and debates that cover all areas of blood cancer, emphasizing in-depth learning and active participation. The single-track format encourages collaboration and fosters the exchange of ideas in a practical, hands-on environment.
By bringing together the world’s foremost educators to discuss the latest scientific advancements, the Congress equips attendees with the tools and insights needed to advance treatment, improve quality of life, and achieve better patient outcomes in hematologic malignancies.
For more posts like this, visit oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023